The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. A variety of strategies have been employed enhance antibody titer, such as process parameter optimization, media optimization, and adoption of perfusion technologies. Fine-tuning media comp